Fluorine in health care Organofluorine containing blockbuster drugs

David O'Hagan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

603 Citations (Scopus)

Abstract

Organic fluorine compounds have had a profound impact on the development of bioactives for the modern pharmaceuticals market It is estimated that up to 20% of pharmaceuticals prescribed or administered in the clinic contain a fluorine atom and 30% of the leading 30 blockbuster drugs by sales contain a fluorine In this Highlight review the top 10 fluorine containing pharmaceuticals (by US Sales in 2008) are highlighted By this measure these are currently the most significant fluorinated compounds impacting on health care They embrace statins (Lipitor Crestor Vytorin Zetia/Ezetimibe) anti-inflammatories (fluticasone propionate Celebrex) antacid (Prevacid) antidepressants (Lexapro) neuroleptics (Risperdal) and antibiotics (Levaquin) In each case the structures and modes of action of these important drugs compounds are reviewed and representative synthetic routes are highlighted (C) 2010 Published by Elsevier BV

Original languageEnglish
Pages (from-to)1071-1081
Number of pages11
JournalJournal of Fluorine Chemistry
Volume131
Issue number11
DOIs
Publication statusPublished - Nov 2010

Keywords

  • LEVOFLOXACIN
  • Statins
  • HMG-COA REDUCTASE
  • Seritonin selective reuptake inhibitors
  • Anti inflammatory
  • SERIES
  • Organofluorine drugs
  • ANALOGS
  • Antibiotics
  • EFFICIENT
  • KEY INTERMEDIATE
  • ENANTIOSELECTIVE SYNTHESIS
  • Neuroleptics
  • CHOLESTEROL ABSORPTION INHIBITORS
  • Antacids
  • LANSOPRAZOLE
  • NUCLEUS

Fingerprint

Dive into the research topics of 'Fluorine in health care Organofluorine containing blockbuster drugs'. Together they form a unique fingerprint.

Cite this